Key Documents
Lawrence Recht
Academic Appointments
- Professor - Med Center Line, Neurology & Neurological Sciences
- Professor - Med Center Line (By courtesy), Neurosurgery
- Member, Cancer Center
Contact Information
-
Clinical Offices
Neurology Department 300 Pasteur Dr P211 MC 5489 Stanford, CA 94305 Tel Work (650) 725-8630 Fax (650) 498-4686Neuro-Oncology Clinic 875 Blake Wilbur Dr Clinic D Stanford, CA 94305-5820 Tel Work (650) 725-8630
- Academic Offices
Personal Information EmailAdministrative Contact Gina Anderson Administrative Assistant Email Tel Work 725-8630Not for medical emergencies or patient use
Professional Snapshot
Clinical Focus
- Cancer > Neuro Oncology
- Neurology
Professional Education
| Fellowship: | Memorial Sloan-Kettering Cancer Center, NY USA (1984) |
| Board Certification: | Neurology, American Board of Psychiatry and Neurology (1983) |
| Residency: | New York Presbyterian Hospital, NY (1982) |
| Residency: | University of Minnesota School of Medicine, MN (1979) |
| Internship: | University of Minnesota School of Medicine, MN (1978) |
Postdoctoral Advisees
Scientific Focus
Research Interests
Our laboratory focuses on two interrelated projects: (1) assessment of glioma development within the framework of the multistage model of carcinogenesis through utilization of the rodent model of ENU neurocarcinogenesis; and (2) assessment of stem cell specification and pluripotency using an embryonic stem cell model system in which neural differentiation is induced.
Clinical Trials
- BIBW 2992 With or Without Daily Temozolomide For Recurrent Malignant Glioma Recruiting
- Phase 2 of Azixa™ (MPC-6827) for Glioblastoma Multiforme in First or Second Relapse Recruiting
- An Open-Labeled, Extended-Use of XERECEPT (hCRF) for Patients in Studies NTI 0302, 0303, or Other Designated Studies Completed
- Phase II/III Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) No longer recruiting
- XERECEPT® (hCRF) for Patients Requiring Dexamethasone to Treat Edema Associated With Brain Tumors Completed
Publications
- A distinct phenotypic change in gliomas at the time of magnetic resonance imaging detection. J Neurosurg. 2008; (4): 782-90
- Tumor necrosis factor-alpha-induced protein 3 as a putative regulator of nuclear factor-kappaB-mediated resistance to O6-alkylating agents in human glioblastomas. J Clin Oncol. 2006; (2): 274-87
- Optimizing therapy for patients with brain metastases. Semin Oncol. 2006; (3): 299-306
- Osteopontin expression in intratumoral astrocytes marks tumor progression in gliomas induced by prenatal exposure to N-ethyl-N-nitrosourea. Am J Pathol. 2006; (5): 1676-85
- Amplification of whole tumor genomes and gene-by-gene mapping of genomic aberrations from limited sources of fresh-frozen and paraffin-embedded DNA. J Mol Diagn. 2005; (2): 171-82
Help